-

ValGenesis Appoints David Medina as Chief Marketing Officer to Spearhead Global Growth Strategy

SANTA CLARA, Calif.--(BUSINESS WIRE)--ValGenesis, the market leader in digital validation and risk management solutions for life sciences, is thrilled to announce the appointment of David Medina as Chief Marketing Officer (CMO), effective September 3, 2024. David joins ValGenesis with an impressive track record of driving marketing success across the enterprise SaaS, life sciences, and technology sectors.

David brings over two decades of experience in strategic marketing, having held senior leadership roles at industry giants such as Honeywell and Sparta Systems, with a deep focus on life sciences. Most recently, as Head of Customer Marketing at Honeywell Connected Enterprise, David led successful digital marketing transformations that generated significant growth in marketing-influenced pipeline for multiple business units.

Prior to his role at Honeywell, David served as CMO at Sparta Systems, where he revamped the company’s marketing strategy, resulting in a 33% CAGR in marketing-sourced revenue. His expertise in life sciences and ability to align marketing efforts with business goals make him the ideal leader to elevate ValGenesis' global brand presence and drive growth in new and existing markets. In his new role, David will oversee ValGenesis' global marketing strategy, brand positioning, and go-to-market initiatives.

“David’s visionary leadership and proven ability to deliver results in complex, competitive environments will be invaluable as we continue to expand our footprint in the life sciences sector. We are confident that his strategic approach to marketing will accelerate our growth and strengthen our position as a leader in digital validation solutions,” said Dr. Siva Samy, CEO & Chief Product Strategist of ValGenesis, Inc.

“I am excited to join ValGenesis at such a pivotal time,” said David Medina. “ValGenesis is at the forefront of innovation in digital validation and risk management, particularly in the life sciences sector. I look forward to working with the team to build on the company’s success and help drive its next growth phase.”

About ValGenesis

ValGenesis, Inc. is a pioneer in providing digital validation software that transforms the validation process for global life sciences companies. With its innovative solutions, ValGenesis enables companies to achieve compliance, reduce risks, and accelerate time-to-market for their products. The company’s platform is widely recognized as the most comprehensive digital validation solution in the market. For more information, visit www.valgenesis.com

Contacts

Althea D’Sylva, ValGenesis Communications, +1 510-445-0505 Ex. 1026, althea.dsylva@valgenesis.com

ValGenesis, Inc.


Release Versions

Contacts

Althea D’Sylva, ValGenesis Communications, +1 510-445-0505 Ex. 1026, althea.dsylva@valgenesis.com

Social Media Profiles
More News From ValGenesis, Inc.

ValGenesis Appoints Wayne Baker as Chief Revenue Officer to Accelerate Global Growth

SANTA CLARA, Calif.--(BUSINESS WIRE)--ValGenesis appoints Wayne Baker as chief revenue officer to lead global revenue strategy and accelerate Smart GxP and VAL adoption....

Leading Public Health Organization Implements ValGenesis Platform

SANTA CLARA, Calif.--(BUSINESS WIRE)--ValGenesis, Inc., the market leader in enterprise digital validation, announced that a leading public health organization has gone live with ValGenesis, marking a significant milestone in its mission to strengthen global health research and preparedness. The organization conducts research focused on addressing infectious diseases and emerging global health challenges, contributing to scientific advancement and improved public health outcomes worldwide. The...

Ulrich Medical Selects ValGenesis iVal™ for SAP-Driven CSV Upgrade

SANTA CLARA, Calif.--(BUSINESS WIRE)--ValGenesis Inc., the market leader in enterprise digital validation, announced that Ulrich Medical has selected ValGenesis iVal™ to modernize computer system validation (CSV) processes in support of its broader digital transformation and upcoming SAP implementation. The Germany-based medical device company will replace manual validation processes with a digital approach to manage increased CSV activity associated with the SAP rollout. The initial deployment...
Back to Newsroom